Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The restaurant group announced Tuesday that Jose Alberto Dueñas is stepping down. Chief financial officer Paul Carbone, a ...

Bloks Group Ltd., the popular maker of Ultraman and Transformers figurines, raised HK$1.67 billion ($215 million) in Hong ...

The initial public offering (IPO) of Standard Glass Lining Technology Ltd enters its third and the last day of bidding today, ...

(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its ...

Spanish travel technology firm HBX Group is considering announcing plans for an initial public offering as early as next week ...

The share allotment of Fabtech Technologies IPO is expected to be finalized soon. Investors can check their allotment status ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Smithfield Foods on Monday made public its paperwork for its New York initial public offering as the maker of Farmland bacon ...

Once the allotment of Fabtech Technologies IPO shares is finalised, investors who applied for the offering can check the ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

The main difference between going public through an initial public offering (IPO) and staying private lies in ownership ...